These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9034354)

  • 21. Single-chain factor XII: a new form of activated factor XII.
    Ivanov I; Matafonov A; Gailani D
    Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulation factor XII induces pro-inflammatory cytokine responses in macrophages and promotes atherosclerosis in mice.
    Vorlova S; Koch M; Manthey HD; Cochain C; Busch M; Chaudhari SM; Stegner D; Yepes M; Lorenz K; Nolte MW; Nieswandt B; Zernecke A
    Thromb Haemost; 2017 Jan; 117(1):176-187. PubMed ID: 27786338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Part of purified human plasma kallikrein removed together with a remaining IgG fraction--immunoblot experiments and functional tests.
    Briseid K; Johannesen S
    Scand J Clin Lab Invest; 2002; 62(1):21-4. PubMed ID: 12002409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
    Esnouf MP; Burgess AI; Dodds AW; Sarphie AF; Miller GJ
    Thromb Haemost; 2000 Jun; 83(6):874-81. PubMed ID: 10896241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes.
    Matata BM; Courtney JM; Sundaram S; Wark S; Bowry SK; Vienken J; Lowe GD
    J Biomed Mater Res; 1996 May; 31(1):63-70. PubMed ID: 8731150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor XII does not initiate prekallikrein activation on endothelial cells.
    Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
    Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contact activation factors in plasma from pregnant women--increased level of an association between factor XII and kallikrein.
    Briseid K; Hoem NO; Johannesen S; Fossum S
    Thromb Res; 1991 Jan; 61(2):123-33. PubMed ID: 2020942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition.
    Truong TK; Malik RA; Yao X; Fredenburgh JC; Stafford AR; Madarati HM; Kretz CA; Weitz JI
    J Thromb Haemost; 2022 Apr; 20(4):821-832. PubMed ID: 34967109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
    Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
    Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains.
    Shamanaev A; Ivanov I; Sun MF; Litvak M; Srivastava P; Mohammed BM; Shaban R; Maddur A; Verhamme IM; McCarty OJT; Law RHP; Gailani D
    Blood Adv; 2022 May; 6(10):3142-3154. PubMed ID: 35086137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.
    Citarella F; Fedele G; Roem D; Fantoni A; Hack CE
    Blood; 1998 Dec; 92(11):4198-206. PubMed ID: 9834224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator.
    Shariat-Madar Z; Mahdi F; Schmaier AH
    J Biol Chem; 2002 May; 277(20):17962-9. PubMed ID: 11830581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation.
    Stroo I; Zeerleder S; Ding C; Luken BM; Roelofs JJTH; de Boer OJ; Meijers JCM; Castellino FJ; van 't Veer C; van der Poll T
    Thromb Haemost; 2017 Jul; 117(8):1601-1614. PubMed ID: 28492700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid and cooperative binding of factor XII to human umbilical vein endothelial cells.
    Schousboe I
    Eur J Biochem; 2001 Jul; 268(14):3958-63. PubMed ID: 11453989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
    Iijima K; Arakawa Y; Sugahara Y; Matsushita M; Moriguchi Y; Shimohiro H; Nakagawa M
    Thromb Haemost; 2011 Mar; 105(3):473-8. PubMed ID: 21264442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
    Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
    Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FXII levels, FXIIa-like activities and kallikrein activities in normal subjects and patients undergoing cardiac surgery.
    Wendel HP; Jones DW; Gallimore MJ
    Immunopharmacology; 1999 Dec; 45(1-3):141-4. PubMed ID: 10615003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antigenic binding site(s) of antibodies to factor XII associated with the antiphospholipid syndrome.
    Harris SL; Jones DW; Gallimore MJ; Nicholls PJ; Winter M
    J Thromb Haemost; 2005 May; 3(5):969-75. PubMed ID: 15869593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kallikrein modification with affinity to IgG present in higher amounts than normal in plasma from patients with Crohn's disease.
    Briseid K; Johannesen S
    Scand J Clin Lab Invest; 2003; 63(6):425-9. PubMed ID: 14594323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive-protein adsorption in contact activation of blood factor XII.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.